Form 4 for ELV Elevance Health
Accepted 2024-04-25 00:00:00 ET · period of report 2024-04-23 · accession 0001415889-24-011527 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-04-25 | 2024-04-23+ | ELV | Norwood Felicia F | EVP, Pres, Gov Health Ben | M - OptEx | $238.27 | +7,516 | 33.5K | +29% | +$1.79M |
| DM | 2024-04-25 | 2024-04-23+ | ELV | Norwood Felicia F | EVP, Pres, Gov Health Ben | S - Sale+OE | $533.34 | -20.3K | 31.5K | -39% | -$10.83M |
| DM | 2024-04-25 | 2024-04-23+ | ELV | Norwood Felicia F | EVP, Pres, Gov Health Ben | M - OptEx | $0.00 | -7,516 | 2,043 | -79% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-23 | M | A | 5,473 | $238.27 | 45,571 | D | — | — | |
| 2 | Common | Common Stock | 2024-04-23 | S | D | 14,011 | $533.73 | 31,560 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $533.60 to $534.52. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2024-04-24 | S | D | 3,434 | $532.68 | 27,304 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $532.44 to $533.30. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2024-04-24 | M | A | 2,043 | $238.27 | 33,503 | D | — | — | |
| 5 | Common | Common Stock | 2024-04-24 | S | D | 2,765 | $532.14 | 30,738 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $531.44 to $532.43. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 6 | Common | Common Stock | 2024-04-23 | S | D | 100 | $534.74 | 31,460 | D | — | — | |
| 7 | Derivative | Employee Stock Option (right to buy) | 2024-04-24 | M | D | 2,043 | $0.00 | 0 | D | $238.27 · — to 2028-07-02 | 2,043 Common Stock | (F4) Fully vested. |
| 8 | Derivative | Employee Stock Option (right to buy) | 2024-04-23 | M | D | 5,473 | $0.00 | 2,043 | D | $238.27 · — to 2028-07-02 | 5,473 Common Stock | (F4) Fully vested. |